Intern with needle prick injury . What to do
Reading File
Finding Sources
Searching the Web
needle stick injury management protocol post exposure prophylaxis 2024
Finding Sources
Finding Sources
Reading File
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
I now have comprehensive, authoritative information from Harrison's and Current Surgical Therapy. Here is the complete management guide:
Needle Prick Injury in an Intern - Complete Management Protocol
STEP 1: IMMEDIATE FIRST AID (Do this right now)
- Wash the wound immediately with soap and water - scrub thoroughly for several minutes
- Apply an alcohol-based antiseptic to the wound
- If eyes/mucous membranes are involved, flush with copious water for 10-15 minutes
- Do NOT squeeze, milk, or apply suction to the wound - no evidence of benefit
- Do NOT use bleach or caustic products (worsens tissue damage)
- Remove gloves and reglove if it occurred through a surgical glove
STEP 2: REPORT AND DOCUMENT (Same day - do not delay)
- Note the source patient's name, hospital number, attending, and ward location
- Report immediately to the supervisor/occupational health/infection control nurse
- Fill out an incident/exposure report form
- Document: type of needle (hollow-bore vs. suture), depth of injury, whether blood was visible on needle, which body fluid was involved
STEP 3: ASSESS RISK OF TRANSMISSION
Highest risk factors (Current Surgical Therapy 14e, p. 1530):
- Hollow-bore needle placed in vein/artery of source patient
- Deep percutaneous injury
- Visible blood on device
- Large inoculum volume
- Source patient with high viral load / advanced disease
Transmission risk per needlestick (aggregate data):
| Pathogen | Risk |
|---|---|
| HBV (HBeAg+) | 37-62% per exposure |
| HBV (HBeAg-) | 23-27% per exposure |
| HCV | ~0.2-1.8% per exposure |
| HIV | ~0.23-0.33% per exposure |
STEP 4: TEST THE SOURCE PATIENT
Order immediately (with consent):
- HIV rapid test (result in <20 min) - 4th generation Ag/Ab preferred
- HBsAg
- HCV Ab (follow with HCV RNA PCR if positive)
If source is high risk or has recent flu-like illness suggestive of acute HIV - order HIV RNA PCR as well.
If source patient is unavailable or unknown - treat based on epidemiological risk.
STEP 5: TEST THE INTERN (BASELINE)
- HIV Ag/Ab (4th generation)
- HBsAg, anti-HBsAb (to confirm vaccination status and immunity)
- HCV Ab + liver function tests
- Hepatitis B vaccination history (check anti-HBs titer)
STEP 6: POST-EXPOSURE PROPHYLAXIS (PEP) - TIME CRITICAL
HIV PEP
- This is a medical emergency - start within 1-2 hours ideally; do NOT delay >72 hours (Harrison's 22E, p. 1665)
- If source tests HIV-negative, PEP can be stopped
- If source tests HIV-positive or high risk: start PEP immediately while awaiting results
Preferred PEP regimen (28 days):
TDF 300 mg + FTC 200 mg (Truvada) once daily + Dolutegravir (DTG) 50 mg once daily
Alternative: TDF/FTC + Raltegravir 400 mg twice daily
- For renal impairment (GFR <50 mL/min): dose-adjust TDF/FTC
- In pregnancy: benefits outweigh risks; AZT/3TC + lopinavir regimen has most safety data; stop breastfeeding during PEP
US PEP Hotline: 888-448-4911 (24/7) - Current Surgical Therapy 14e
Hepatitis B (HBV) Management
| Intern's HBV status | Source HBsAg+ | Source HBsAg unknown | Source HBsAg- |
|---|---|---|---|
| Vaccinated & anti-HBs ≥10 mIU/mL | No action needed | No action needed | No action needed |
| Unvaccinated | HBIG 0.06 mL/kg IM x1 + start HBV vaccine series | HBIG + vaccine | Start vaccine series only |
| Vaccinated, non-responder (anti-HBs <10) | HBIG x2 (1 month apart) + vaccine | Treat as positive if high risk | Nothing |
| Vaccinated, response unknown | Test anti-HBs, then decide | Test source, then decide | Nothing |
Hepatitis C (HCV) Management
- No post-exposure prophylaxis exists for HCV - immune globulin is NOT recommended
- If source has chronic HCV (HCV Ab + AND HCV RNA+):
- Baseline HCV Ab + LFTs at time of exposure
- HCV RNA PCR at 4-6 weeks post-exposure
- Repeat HCV Ab + LFTs at 6 months
- If HCV RNA positive at 4 weeks - treat with standard HCV antivirals (>99% cure rate; same regimens as chronic HCV)
Tetanus
- Check tetanus vaccination status - update if not current (especially for deep/contaminated wounds)
STEP 7: FOLLOW-UP MONITORING
| Test | Timepoints |
|---|---|
| HIV Ag/Ab (4th gen) | Baseline, 6 weeks, 12 weeks, 4-6 months |
| HBsAb | 1-2 months after vaccine if initiated |
| HCV Ab + LFTs | Baseline and 6 months (if source HCV+) |
| HCV RNA PCR | 4-6 weeks (if source HCV RNA+) |
4th generation HIV Ag/Ab tests will be positive within 14 days of infection and always positive by 4 months - so follow-up can be concluded at 4-6 months with negative results.
STEP 8: COUNSELING THE INTERN
- Abstain from unprotected sex until source patient's HIV serology is confirmed negative
- Do not donate blood or organs during the monitoring period
- If breastfeeding and on HIV PEP - pump and discard milk during treatment
- Reassure: overall transmission risk is low, especially for HIV (0.23%), and PEP reduces this to near zero if taken properly
- Address emotional distress - needle prick injuries cause significant anxiety
Sources: Current Surgical Therapy 14e (pp. 1529-1535); Harrison's Principles of Internal Medicine 22E (2025), p. 1665
This is a shared conversation. Sign in to Orris to start your own chat.